Share Price and Basic Stock Data
Last Updated: January 29, 2026, 6:05 pm
| PEG Ratio | -1.53 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Deccan Cements Ltd operates in the cement industry, with a current share price of ₹639 and a market capitalization of ₹896 Cr. The company reported a total sales figure of ₹782 Cr for the fiscal year ending March 2023, showing a slight decline from ₹792 Cr in the previous year. The sales figures exhibited volatility in the recent quarters, with the highest quarterly sales of ₹216.86 Cr reported in December 2023, followed by a decline to ₹167.25 Cr in September 2023. This fluctuation suggests exposure to market conditions and demand variability. The company’s revenue from operations per share stands at ₹376.21, while total liabilities reached ₹1,625 Cr as of March 2025. The cash conversion cycle, which stood at 386 days, indicates a longer time frame to convert investments into cash, reflecting potential inefficiencies in working capital management. Overall, the revenue trajectory shows a need for strategic adjustments to stabilize and grow sales amidst challenging market dynamics.
Profitability and Efficiency Metrics
Deccan Cements reported a net profit of ₹49 Cr for the fiscal year ending March 2023, down from ₹88 Cr the previous year, reflecting a declining trend in profitability. The operating profit margin (OPM) was recorded at 12% in March 2023, significantly lower than the 20% achieved in March 2022. Quarterly OPM figures further illustrate this volatility, with the highest margin of 13.18% in December 2023, contrasting sharply with a low of 8.19% in September 2023. The return on equity (ROE) stood at a modest 0.75%, and return on capital employed (ROCE) was recorded at 1.53%, both indicating inefficiencies in generating returns relative to shareholder investments. The interest coverage ratio (ICR) of 4.04x suggests that the company can comfortably meet its interest obligations, but the overall profitability metrics highlight the challenges in cost management and operational efficiency. This situation necessitates a thorough review of cost structures and operational processes to enhance profitability.
Balance Sheet Strength and Financial Ratios
As of March 2025, Deccan Cements reported total assets of ₹1,700 Cr, with total liabilities at ₹1,625 Cr, indicating a leveraged position with a debt-to-equity ratio of 0.98x. The company’s borrowings rose to ₹760 Cr, reflecting an increased reliance on debt financing. Reserves also increased to ₹739 Cr, demonstrating some accumulation of retained earnings. The price-to-book value (P/BV) ratio stood at 1.52x, suggesting a moderate valuation relative to book value, while the cash earnings per share was reported at ₹25.41. The current ratio of 1.17x implies adequate short-term liquidity, though the quick ratio of 0.82x indicates potential challenges in meeting short-term obligations without relying on inventory sales. The financial ratios suggest a mixed picture; while liquidity appears manageable, the high leverage could pose risks, particularly in an environment of rising interest rates or declining demand.
Shareholding Pattern and Investor Confidence
Deccan Cements’ shareholding pattern reveals a stable promoter holding of 56.24%, indicating a strong commitment from the founders and management. Foreign institutional investors (FIIs) accounted for 9.93% of the shareholding as of September 2025, showing a slight decrease from a peak of 11.87% in September 2024. Domestic institutional investors (DIIs) held a minor 0.90%, while public shareholders constituted 32.92%. The overall decline in the number of shareholders from 17,605 in December 2022 to 11,952 by September 2025 suggests some dilution of retail investor interest. However, the relatively high promoter stake signals confidence in the company’s long-term prospects, which is essential for maintaining investor trust. The stability in promoter ownership, coupled with a modest presence of institutional investors, may provide a buffer against market volatility, though the declining public shareholder base raises concerns about broader market sentiment.
Outlook, Risks, and Final Insight
The outlook for Deccan Cements appears mixed. On one hand, the company’s financial metrics indicate a need for operational improvements to enhance profitability and efficiency. The declining net profit and OPM trends, alongside a high cash conversion cycle, signal potential challenges in sustaining growth. Key risks include rising input costs, which could further pressure margins, and increased competition in the cement sector. Additionally, the elevated leverage could become a concern if market conditions worsen or interest rates rise. However, the substantial promoter ownership may provide stability and strategic direction. For Deccan Cements to navigate these hurdles successfully, it will be essential to implement robust cost management strategies and optimize operational efficiencies. In summary, while the company has a solid foundation, addressing these weaknesses will be critical for its future performance and market positioning.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 19.5/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,74,677 Cr. | 12,717 | 13,102/10,048 | 48.2 | 2,444 | 0.61 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 26,044 Cr. | 1,102 | 1,209/788 | 135 | 322 | 0.18 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 13,804 Cr. | 445 | 490/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 8,679 Cr. | 215 | 309/197 | 28.7 | 74.4 | 0.47 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 38,622.46 Cr | 1,946.88 | 36.51 | 573.47 | 0.57% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 180.46 | 211.13 | 195.94 | 192.08 | 167.25 | 216.86 | 223.24 | 172.15 | 120.46 | 115.45 | 118.92 | 150.56 | 140.31 |
| Expenses | 163.64 | 186.08 | 175.42 | 166.86 | 153.55 | 188.28 | 196.93 | 160.83 | 118.27 | 106.70 | 105.80 | 122.68 | 120.15 |
| Operating Profit | 16.82 | 25.05 | 20.52 | 25.22 | 13.70 | 28.58 | 26.31 | 11.32 | 2.19 | 8.75 | 13.12 | 27.88 | 20.16 |
| OPM % | 9.32% | 11.86% | 10.47% | 13.13% | 8.19% | 13.18% | 11.79% | 6.58% | 1.82% | 7.58% | 11.03% | 18.52% | 14.37% |
| Other Income | 1.74 | 1.68 | 3.14 | 3.15 | 3.67 | 4.28 | -11.43 | 3.02 | 2.89 | 3.31 | 6.98 | 2.74 | 2.32 |
| Interest | 2.71 | 3.30 | 3.50 | 2.42 | 2.86 | 3.83 | 3.27 | 3.02 | 3.41 | 3.51 | 2.81 | 3.47 | 3.27 |
| Depreciation | 6.90 | 6.89 | 6.78 | 6.81 | 6.92 | 6.96 | 6.94 | 7.01 | 7.11 | 7.07 | 6.89 | 6.68 | 6.74 |
| Profit before tax | 8.95 | 16.54 | 13.38 | 19.14 | 7.59 | 22.07 | 4.67 | 4.31 | -5.44 | 1.48 | 10.40 | 20.47 | 12.47 |
| Tax % | 26.59% | 26.48% | 26.08% | 26.12% | 37.55% | 30.31% | 35.76% | 34.80% | -25.92% | 45.27% | 23.65% | 24.96% | 27.19% |
| Net Profit | 6.57 | 12.16 | 9.90 | 14.14 | 4.73 | 15.39 | 3.01 | 2.81 | -4.04 | 0.81 | 7.95 | 15.35 | 9.07 |
| EPS in Rs | 4.69 | 8.68 | 7.07 | 10.09 | 3.38 | 10.99 | 2.15 | 2.01 | -2.88 | 0.58 | 5.68 | 10.96 | 6.48 |
Last Updated: January 1, 2026, 11:32 pm
Below is a detailed analysis of the quarterly data for Deccan Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 140.31 Cr.. The value appears to be declining and may need further review. It has decreased from 150.56 Cr. (Jun 2025) to 140.31 Cr., marking a decrease of 10.25 Cr..
- For Expenses, as of Sep 2025, the value is 120.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 122.68 Cr. (Jun 2025) to 120.15 Cr., marking a decrease of 2.53 Cr..
- For Operating Profit, as of Sep 2025, the value is 20.16 Cr.. The value appears to be declining and may need further review. It has decreased from 27.88 Cr. (Jun 2025) to 20.16 Cr., marking a decrease of 7.72 Cr..
- For OPM %, as of Sep 2025, the value is 14.37%. The value appears to be declining and may need further review. It has decreased from 18.52% (Jun 2025) to 14.37%, marking a decrease of 4.15%.
- For Other Income, as of Sep 2025, the value is 2.32 Cr.. The value appears to be declining and may need further review. It has decreased from 2.74 Cr. (Jun 2025) to 2.32 Cr., marking a decrease of 0.42 Cr..
- For Interest, as of Sep 2025, the value is 3.27 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.47 Cr. (Jun 2025) to 3.27 Cr., marking a decrease of 0.20 Cr..
- For Depreciation, as of Sep 2025, the value is 6.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.68 Cr. (Jun 2025) to 6.74 Cr., marking an increase of 0.06 Cr..
- For Profit before tax, as of Sep 2025, the value is 12.47 Cr.. The value appears to be declining and may need further review. It has decreased from 20.47 Cr. (Jun 2025) to 12.47 Cr., marking a decrease of 8.00 Cr..
- For Tax %, as of Sep 2025, the value is 27.19%. The value appears to be increasing, which may not be favorable. It has increased from 24.96% (Jun 2025) to 27.19%, marking an increase of 2.23%.
- For Net Profit, as of Sep 2025, the value is 9.07 Cr.. The value appears to be declining and may need further review. It has decreased from 15.35 Cr. (Jun 2025) to 9.07 Cr., marking a decrease of 6.28 Cr..
- For EPS in Rs, as of Sep 2025, the value is 6.48. The value appears to be declining and may need further review. It has decreased from 10.96 (Jun 2025) to 6.48, marking a decrease of 4.48.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 441 | 407 | 625 | 496 | 570 | 651 | 555 | 758 | 792 | 782 | 799 | 527 | 525 |
| Expenses | 383 | 343 | 511 | 396 | 484 | 556 | 477 | 582 | 630 | 684 | 704 | 492 | 455 |
| Operating Profit | 57 | 64 | 115 | 100 | 86 | 95 | 79 | 176 | 162 | 97 | 96 | 35 | 70 |
| OPM % | 13% | 16% | 18% | 20% | 15% | 15% | 14% | 23% | 20% | 12% | 12% | 7% | 13% |
| Other Income | 2 | 3 | 1 | 2 | 3 | 10 | -0 | 10 | -8 | 9 | -2 | 16 | 15 |
| Interest | 27 | 27 | 15 | 7 | 6 | 8 | 7 | 8 | 10 | 13 | 13 | 13 | 13 |
| Depreciation | 24 | 19 | 20 | 22 | 23 | 22 | 21 | 23 | 26 | 27 | 28 | 28 | 27 |
| Profit before tax | 7 | 21 | 81 | 74 | 61 | 75 | 51 | 155 | 117 | 67 | 53 | 11 | 45 |
| Tax % | 33% | 6% | 43% | 36% | 37% | 39% | -12% | 26% | 25% | 26% | 30% | 30% | |
| Net Profit | 5 | 20 | 46 | 47 | 39 | 46 | 57 | 115 | 88 | 49 | 37 | 8 | 33 |
| EPS in Rs | 3.59 | 14.20 | 32.54 | 33.48 | 27.52 | 32.88 | 40.44 | 82.19 | 62.52 | 35.20 | 26.60 | 5.38 | 23.70 |
| Dividend Payout % | 17% | 9% | 8% | 9% | 11% | 11% | 10% | 6% | 8% | 11% | 11% | 11% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 300.00% | 130.00% | 2.17% | -17.02% | 17.95% | 23.91% | 101.75% | -23.48% | -44.32% | -24.49% | -78.38% |
| Change in YoY Net Profit Growth (%) | 0.00% | -170.00% | -127.83% | -19.20% | 34.97% | 5.96% | 77.84% | -125.23% | -20.84% | 19.83% | -53.89% |
Deccan Cements Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -1% |
| 3 Years: | -13% |
| TTM: | -35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -35% |
| 3 Years: | -58% |
| TTM: | -51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 28% |
| 1 Year: | 71% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 223 | 238 | 279 | 325 | 358 | 399 | 443 | 558 | 639 | 680 | 712 | 715 | 739 |
| Borrowings | 239 | 191 | 79 | 70 | 33 | 54 | 106 | 104 | 166 | 265 | 520 | 714 | 760 |
| Other Liabilities | 119 | 114 | 127 | 132 | 161 | 161 | 155 | 193 | 173 | 202 | 207 | 189 | 194 |
| Total Liabilities | 588 | 550 | 493 | 535 | 560 | 621 | 710 | 861 | 985 | 1,155 | 1,446 | 1,625 | 1,700 |
| Fixed Assets | 373 | 356 | 342 | 377 | 363 | 354 | 378 | 446 | 453 | 440 | 423 | 402 | 389 |
| CWIP | 35 | 33 | 34 | 0 | 4 | 9 | 62 | 12 | 21 | 241 | 514 | 805 | 895 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 180 | 161 | 116 | 157 | 192 | 258 | 271 | 404 | 511 | 474 | 509 | 417 | 416 |
| Total Assets | 588 | 550 | 493 | 535 | 560 | 621 | 710 | 861 | 985 | 1,155 | 1,446 | 1,625 | 1,700 |
Below is a detailed analysis of the balance sheet data for Deccan Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Reserves, as of Sep 2025, the value is 739.00 Cr.. The value appears strong and on an upward trend. It has increased from 715.00 Cr. (Mar 2025) to 739.00 Cr., marking an increase of 24.00 Cr..
- For Borrowings, as of Sep 2025, the value is 760.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 714.00 Cr. (Mar 2025) to 760.00 Cr., marking an increase of 46.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 194.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 189.00 Cr. (Mar 2025) to 194.00 Cr., marking an increase of 5.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,700.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,625.00 Cr. (Mar 2025) to 1,700.00 Cr., marking an increase of 75.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 389.00 Cr.. The value appears to be declining and may need further review. It has decreased from 402.00 Cr. (Mar 2025) to 389.00 Cr., marking a decrease of 13.00 Cr..
- For CWIP, as of Sep 2025, the value is 895.00 Cr.. The value appears strong and on an upward trend. It has increased from 805.00 Cr. (Mar 2025) to 895.00 Cr., marking an increase of 90.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 416.00 Cr.. The value appears to be declining and may need further review. It has decreased from 417.00 Cr. (Mar 2025) to 416.00 Cr., marking a decrease of 1.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,700.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,625.00 Cr. (Mar 2025) to 1,700.00 Cr., marking an increase of 75.00 Cr..
However, the Borrowings (760.00 Cr.) are higher than the Reserves (739.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -182.00 | -127.00 | 36.00 | 30.00 | 53.00 | 41.00 | -27.00 | 72.00 | -4.00 | -168.00 | -424.00 | -679.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 22 | 27 | 5 | 8 | 9 | 9 | 31 | 12 | 11 | 13 | 25 | 40 |
| Inventory Days | 935 | 712 | 397 | 464 | 364 | 374 | 493 | 341 | 349 | 601 | 408 | 541 |
| Days Payable | 164 | 152 | 150 | 25 | 16 | 27 | 169 | 218 | 132 | 291 | 164 | 194 |
| Cash Conversion Cycle | 793 | 587 | 251 | 446 | 357 | 356 | 355 | 135 | 227 | 323 | 268 | 386 |
| Working Capital Days | 27 | 15 | -2 | 3 | 22 | 10 | 1 | -34 | -51 | -32 | -45 | -65 |
| ROCE % | 7% | 11% | 24% | 21% | 17% | 19% | 13% | 27% | 20% | 9% | 8% | 2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 5.00 |
| Basic EPS (Rs.) | 5.37 |
| Diluted EPS (Rs.) | 5.37 |
| Cash EPS (Rs.) | 25.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 515.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 515.74 |
| Revenue From Operations / Share (Rs.) | 376.21 |
| PBDIT / Share (Rs.) | 36.81 |
| PBIT / Share (Rs.) | 16.77 |
| PBT / Share (Rs.) | 7.67 |
| Net Profit / Share (Rs.) | 5.37 |
| NP After MI And SOA / Share (Rs.) | 5.37 |
| PBDIT Margin (%) | 9.78 |
| PBIT Margin (%) | 4.45 |
| PBT Margin (%) | 2.03 |
| Net Profit Margin (%) | 1.42 |
| NP After MI And SOA Margin (%) | 1.42 |
| Return on Networth / Equity (%) | 1.04 |
| Return on Capital Employeed (%) | 1.76 |
| Return On Assets (%) | 0.46 |
| Long Term Debt / Equity (X) | 0.75 |
| Total Debt / Equity (X) | 0.98 |
| Current Ratio (X) | 1.17 |
| Quick Ratio (X) | 0.82 |
| Dividend Payout Ratio (NP) (%) | 55.89 |
| Dividend Payout Ratio (CP) (%) | 11.80 |
| Earning Retention Ratio (%) | 44.11 |
| Cash Earning Retention Ratio (%) | 88.20 |
| Interest Coverage Ratio (X) | 4.04 |
| Interest Coverage Ratio (Post Tax) (X) | 1.59 |
| Enterprise Value (Cr.) | 1670.92 |
| EV / Net Operating Revenue (X) | 3.17 |
| EV / EBITDA (X) | 32.40 |
| MarketCap / Net Operating Revenue (X) | 2.09 |
| Retention Ratios (%) | 44.10 |
| Price / BV (X) | 1.52 |
| Price / Net Operating Revenue (X) | 2.09 |
| EarningsYield | 0.01 |
After reviewing the key financial ratios for Deccan Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 25.41. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 376.21. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 36.81. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.77. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.67. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 9.78. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 4.45. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.76. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.75. This value is within the healthy range. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.98. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 55.89. This value exceeds the healthy maximum of 50. No previous period data is available for comparison.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 11.80. This value is below the healthy minimum of 20. No previous period data is available for comparison.
- For Earning Retention Ratio (%), as of Mar 25, the value is 44.11. This value is within the healthy range. No previous period data is available for comparison.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 88.20. This value exceeds the healthy maximum of 70. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.04. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,670.92. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 32.40. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
- For Retention Ratios (%), as of Mar 25, the value is 44.10. This value is within the healthy range. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 1.52. This value is within the healthy range. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Deccan Cements Ltd:
- Net Profit Margin: 1.42%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.76% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.04% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.82
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 27 (Industry average Stock P/E: 36.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.98
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.42%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Deccan Chambers, Hyderabad Telangana 500082 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. P Parvathi | Chairperson & Managing Director |
| Mr. S Venkateswarlu | Whole Time Director |
| Mrs. Mahpara Ali | Director |
| Mr. Paturi Srinivasa Rao | Director |
| Mr. Srivari Chandrasekhar | Director |
| Mr. Rabindra Srikantan | Director |
FAQ
What is the intrinsic value of Deccan Cements Ltd?
Deccan Cements Ltd's intrinsic value (as of 29 January 2026) is ₹71.18 which is 88.83% lower the current market price of ₹637.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹895 Cr. market cap, FY2025-2026 high/low of ₹1,184/575, reserves of ₹739 Cr, and liabilities of ₹1,700 Cr.
What is the Market Cap of Deccan Cements Ltd?
The Market Cap of Deccan Cements Ltd is 895 Cr..
What is the current Stock Price of Deccan Cements Ltd as on 29 January 2026?
The current stock price of Deccan Cements Ltd as on 29 January 2026 is ₹637.
What is the High / Low of Deccan Cements Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Deccan Cements Ltd stocks is ₹1,184/575.
What is the Stock P/E of Deccan Cements Ltd?
The Stock P/E of Deccan Cements Ltd is 27.0.
What is the Book Value of Deccan Cements Ltd?
The Book Value of Deccan Cements Ltd is 533.
What is the Dividend Yield of Deccan Cements Ltd?
The Dividend Yield of Deccan Cements Ltd is 0.09 %.
What is the ROCE of Deccan Cements Ltd?
The ROCE of Deccan Cements Ltd is 1.53 %.
What is the ROE of Deccan Cements Ltd?
The ROE of Deccan Cements Ltd is 0.75 %.
What is the Face Value of Deccan Cements Ltd?
The Face Value of Deccan Cements Ltd is 5.00.